ArticleJournal of experimental & clinical cancer research : CR2023

ACTN1 promotes HNSCC tumorigenesis and cisplatin resistance by enhancing MYH9-dependent degradation of GSK-3β and integrin β1-mediated phosphorylation of FAK.

Li Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.